# Stress, Diurnal Cortisol, and Breast Cancer Survival

> **NCT00226967** · — · COMPLETED · sponsor: **Stanford University** · enrollment: 115 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Sandostatin

## Key facts

- **NCT ID:** NCT00226967
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09-08
- **Primary completion:** 2004-11
- **Final completion:** 2005-12
- **Target enrollment:** 115 (ESTIMATED)
- **Last updated:** 2020-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00226967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00226967, "Stress, Diurnal Cortisol, and Breast Cancer Survival". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00226967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*